Literature DB >> 12960165

Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway.

Alexander Hess1, Nastiti Wijayanti, Andrea Pathe Neuschäfer-Rube, Norbert Katz, Thomas Kietzmann, Stephan Immenschuh.   

Abstract

The antioxidant protein peroxiredoxin (Prx) I is a thioredoxin peroxidase that is involved in the regulation of proliferation and differentiation of mammalian cells. Here, it is shown that Prx I gene expression was induced transcriptionally by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) in cultured rat liver tissue macrophages and RAW264.7 monocytic cells. TPA-dependent induction of Prx I gene expression was mediated by two proximal activator protein-1 sites of the rat Prx I promoter region that were nuclear targets of c-Jun as determined by transfection studies with luciferase reporter gene constructs and electrophoretic mobility shift assays. The transcription factor Nrf2, however, was not involved in the regulation of Prx I promoter activity. Prx I gene induction by TPA was decreased by protein kinase C inhibitors and overexpressed dominant negative forms of Ras and MEKK1, but not Raf-1. The p38 MAPK inhibitor SB202190 and overexpression of dominant negative mutants of MAPK kinase 4 (MKK4), MKK6, and p38 inhibited the TPA-dependent induction of Prx I gene transcription. In contrast, inhibitors of the JNK, SP600125, and the NF-kappaB signaling pathway, caffeic acid phenethyl ester, respectively, as well as overexpressed dominant negative MKK7 and IkappaB, had no effect on the up-regulation of Prx I reporter gene activity by TPA. Cotransfection of wild-type p38alpha and p38beta, but not that of p38gamma and p38delta, increased Prx I promoter activity. The data indicate that a protein kinase C, Ras, MEKK1, p38 MAPK signaling pathway plays a major role for the transcriptional up-regulation of Prx I gene expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960165     DOI: 10.1074/jbc.M307871200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Caffeic acid phenethyl ester inhibits liver fibrosis in rats.

Authors:  Mei Li; Xiu-Fang Wang; Juan-Juan Shi; Ya-Ping Li; Ning Yang; Song Zhai; Shuang-Suo Dang
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

2.  Screening of natural compounds as activators of the keap1-nrf2 pathway.

Authors:  Kai C Wu; Peter R McDonald; Jie Liu; Curtis D Klaassen
Journal:  Planta Med       Date:  2013-12-05       Impact factor: 3.352

3.  Phorbol ester enhances KAI1 transcription by recruiting Tip60/Pontin complexes.

Authors:  Alexandra Rowe; Jörg Weiske; Tobias S Kramer; Otmar Huber; Paul Jackson
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

4.  PKCzeta protects against UV-C-induced apoptosis by inhibiting acid sphingomyelinase-dependent ceramide production.

Authors:  Alexandra Charruyer; Christine Jean; Audrey Colomba; Jean-Pierre Jaffrézou; Anne Quillet-Mary; Guy Laurent; Christine Bezombes
Journal:  Biochem J       Date:  2007-07-01       Impact factor: 3.857

5.  Anti-cancer effect of snake venom toxin through down regulation of AP-1 mediated PRDX6 expression.

Authors:  Hye Lim Lee; Mi Hee Park; Dong Ju Son; Ho Sueb Song; Jung Hyun Kim; Seong Cheol Ko; Min Jong Song; Won Hyoung Lee; Joo Hee Yoon; Young Wan Ham; Sang Bae Han; Jin Tae Hong
Journal:  Oncotarget       Date:  2015-09-08

Review 6.  2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications.

Authors:  Sang Won Kang; Sue Goo Rhee; Tong-Shin Chang; Woojin Jeong; Min Hee Choi
Journal:  Trends Mol Med       Date:  2005-11-09       Impact factor: 11.951

Review 7.  Cell stress proteins in atherothrombosis.

Authors:  Julio Madrigal-Matute; Roxana Martinez-Pinna; Carlos Ernesto Fernandez-Garcia; Priscila Ramos-Mozo; Elena Burillo; Jesus Egido; Luis Miguel Blanco-Colio; Jose Luis Martin-Ventura
Journal:  Oxid Med Cell Longev       Date:  2012-06-25       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.